<p>The Center for Cancer Research (CCR), of the intramural NCI undertook a multidimensional clinical genomics study of children and adolescent young adults with relapsed and refractory cancers who were enrolled on other therapeutic trials to determine the feasibility of a genome guided precision therapy protocol in these patients.</p><p>Note: NCIPM001blood - This sample was previously submitted with study <a href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002207">phs002207</a>, with sample ID NCIPM001blood_E and SRR ID SRR18544311.</p>

Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children    and Adolescent Young Adults with Relapsed and Refractory Cancer: A    Report from the Center for Cancer Research

15 variables across Demographics, Disease Events

Variables — phs001052 — Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children    and Adolescent Young Adults with Relapsed and Refractory Cancer: A    Report from the Center for Cancer Research

Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research

Demographics (3)

Disease Events (1)

Other (11)